What is the half-life of BPC-157 (Cognitive Applications)?

BPC-157 (Cognitive Applications) has a half-life of ~4-6 hours (estimated from animal pharmacokinetic data), which is why it's typically administered 1-2 times daily for optimal therapeutic effect.

How do I reconstitute BPC-157 (Cognitive Applications)?

Add bacteriostatic water to the peptide vial slowly down the side. Typical reconstitution uses 2-3ml of water for a 5mg vial. Gently swirl, do not shake.

Healing & Recovery

Preclinical

BPC-157 (Cognitive Applications)

Also known as: BPC-157, Bepecin, PL-10, PL 14736

Overview

Key Facts

Primary Goal: A 15-amino acid partial sequence of human gastric juice body protection compound

A 15-amino acid partial sequence of human gastric juice body protection compound. While primarily categorized as a healing and recovery peptide, BPC-157 demonstrates significant neuroprotective and neuroregenerative properties relevant to cognitive enhancement, including dopaminergic system modulation, traumatic brain injury recovery, and nerve growth support. Cross-reference with the healing-recovery category for its primary tissue-repair profile. Half-Life ~4-6 hours (estimated from animal pharmacokinetic data) Typical Dose 200–500 mcg Frequency 1-2 times daily Cycle Length 4-12 weeks

Dosing Information

Half-Life

~4-6 hours (estimated from animal pharmacokinetic data)

Typical Dose

200–500 mcg

Frequency

1-2 times daily

Cycle Length

4-12 weeks

Administration Routes:

subcutaneousoral

Storage & Reconstitution

Unreconstituted (Powder)

Temperature2–8°C (36–46°F) or -20°C (-4°F) for long-term

DurationUp to 3 months

Reconstituted (Mixed)

Temperature2–8°C (36–46°F)

Duration2-4 weeks

Research Summary

Preclinical

BPC-157 has been studied extensively in preclinical models for its neuroprotective properties beyond its well-known tissue healing effects. Research published in journals including Current Neuropharmacology and Regulatory Peptides has demonstrated its ability to counteract dopaminergic neurotoxicity (amphetamine, haloperidol), protect against traumatic brain injury, and promote peripheral nerve regeneration following transection injuries. Its interaction with the NO system and dopamine pathways makes it relevant to cognitive function, though human clinical trials for cognitive indications have not been conducted.